Activation of FXR pathway does not alter glial cell function

BACKGROUND: The nuclear receptor farnesoid-X-receptor (FXR; NR1H4) is expressed not only in the liver, gut, kidney and adipose tissue but also in the immune cells. FXR has been shown to confer protection in several animal models of inflammation, including experimental autoimmune encephalomyelitis (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Stefanie, Fleck, Ann-Katrin, Kirchberg, Ina, Hucke, Stephanie, Liebmann, Marie, Klotz, Luisa, Kuhlmann, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371249/
https://www.ncbi.nlm.nih.gov/pubmed/28351411
http://dx.doi.org/10.1186/s12974-017-0833-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371249/
https://www.ncbi.nlm.nih.gov/pubmed/28351411
http://dx.doi.org/10.1186/s12974-017-0833-6

Ejemplares similares